Neuberger Berman Group
BIOR

Neuberger Berman Group’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Neuberger Berman Group’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-26,164
Closed -$3.17M – 1908
2022
Q3 		$3.17M Hold
26,164
– – ﹤0.01% 984
2022
Q2 		$4.58M Hold
26,164
– – ﹤0.01% 916
2022
Q1 		$7.59M Buy
26,164
+7,831
+43% +$2.97M 0.01% 866
2021
Q4 		$9.58M Sell
18,333
-7,831
-30% -$5.62M 0.01% 831
2021
Q3 		$9.94M Hold
26,164
– – 0.01% 807
2021
Q2 		$23.4M Hold
26,164
– – 0.02% 660
2021
Q1 		$31.1M Hold
26,164
– – 0.03% 569
2020
Q4 		$34.7M Hold
26,164
– – 0.04% 501
2020
Q3 		$59M Hold
26,164
– – 0.07% 334
2020
Q2 		$58.9M Buy
+26,164
New +$71.2M 0.07% 334

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
WA
WealthTrust Axiom Wayne, Pennsylvania $406M AUM 40.44% 1-Year Est. Return

Neuberger Berman Group's BIOR Position: Q4 2022 in Review

Neuberger Berman Group sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2022, closing a stake of 26,164 shares — an estimated $3.17M sold.

Neuberger Berman Group first reported a position in BIOR in Q2 2020 and held it in 10 quarters. The position peaked at $59M in Q3 2020. 42 funds tracked by Wall St. Rank hold BIOR as of Q4 2022.

  • Neuberger Berman Group reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Neuberger Berman Group sold 26,164 Biora Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $3.17M.
  • Neuberger Berman Group first reported a position in Biora Therapeutics, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
  • Neuberger Berman Group's Biora Therapeutics, Inc. Common Stock position peaked at $59M in Q3 2020.
  • 42 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Neuberger Berman Group's 13F filing for Q4 2022, filed 13 Feb 2023.